Emcure Pharmaceuticals Ltd. — documents
41 files on disk. SHA-256 from the acquisition manifests; links open the exchange copy.
| Class | Period | Scope / kind | Filing date | File | SHA-256 |
|---|---|---|---|---|---|
| Results XBRL (NSE) | 2024-06-30 | Standalone | — | INDAS_111943_1224523_13082024095905.xml | 8092c6fc73dd86b8 |
| Results XBRL (NSE) | 2024-06-30 | Consolidated | — | INDAS_111948_1224543_13082024101216.xml | 7fbe7b2c25132650 |
| Results XBRL (NSE) | 2024-09-30 | Standalone | — | INDAS_114505_1301153_08112024020204.xml | 9e5b3cfb1605875c |
| Results XBRL (NSE) | 2024-09-30 | Consolidated | — | INDAS_114507_1301164_08112024020502.xml | 13359694ab696061 |
| Results XBRL (NSE) | 2024-12-31 | Standalone | — | INDAS_118841_1372708_06022025032928.xml | 3f0f6314ceb1cfb3 |
| Results XBRL (NSE) | 2024-12-31 | Consolidated | — | INDAS_118846_1372723_06022025033359.xml | 8f921e1d9b296575 |
| Results XBRL (NSE) | 2025-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1447837_22052025 | 73154d0edfe954b2 |
| Results XBRL (NSE) | 2025-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1447905_22052025 | ba055816955882c0 |
| Results XBRL (NSE) | 2025-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1504875_07082025 | 4d4ca483deeab6d4 |
| Results XBRL (NSE) | 2025-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1504876_07082025 | a952dbcd7e9198db |
| Results XBRL (NSE) | 2025-09-30 | Standalone | — | INTEGRATED_FILING_INDAS_1571091_11112025 | 15f5961a6b46caf4 |
| Results XBRL (NSE) | 2025-09-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1571105_11112025 | ab2db5f9f9b0e494 |
| Results XBRL (NSE) | 2025-12-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1617872_04022026 | b6655e920506484e |
| Results XBRL (NSE) | 2025-12-31 | Standalone | — | INTEGRATED_FILING_INDAS_1617873_04022026 | cb51f79b420c8dc6 |
| Results XBRL (NSE) | 2026-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1663827_05052026 | 523f83f08749a764 |
| Results XBRL (NSE) | 2026-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1663874_05052026 | e59cf87df45137f5 |
| Results XBRL (NSE) | 2026-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1708917_06082026 | c6e602899797d0ee |
| Results XBRL (NSE) | 2026-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1708919_06082026 | bc7bcbb22d6ee1dd |
| Annual report | 2025-03-31 | grade A | 2025-08-02T16:49:40.073 | 4fa3f6b5-6c40-45ed-8a66-ad9c4336d473.pdf | 809a489ad180f7b1 |
| Annual report | 2026-03-31 | grade A | 2026-08-28T20:37:07.78 | 0cc76dbe-0609-4d8c-b2ea-ef15affd0b7e.pdf | 7890d4f86acfd0ab |
| Concall | 2024-06-30 | TRANSCRIPT | — | Date_20240819_Emcure Pharmaceuticals Ltd._Concal_Q1FY25.pdf | 6a65cf8bf0915d4b |
| Concall | 2024-06-30 | DUPLICATE | — | Date_20240819_Emcure Pharmaceuticals Ltd._Concal_Q1FY25_v2.p | 406ab11201458748 |
| Concall | 2024-09-30 | TRANSCRIPT | — | Date_20241113_Emcure Pharmaceuticals Ltd._Concal_Q2FY25.pdf | 65ab24c539db6da1 |
| Concall | 2024-09-30 | DUPLICATE | — | Date_20241113_Emcure Pharmaceuticals Ltd._Concal_Q2FY25_v2.p | 77f4add6e41783d8 |
| Concall | 2024-12-31 | TRANSCRIPT | — | Date_20250211_Emcure Pharmaceuticals Ltd._Concal_Q3FY25.pdf | 9131e5a3dd557525 |
| Concall | 2025-03-31 | TRANSCRIPT | — | Date_20250528_Emcure Pharmaceuticals Ltd._Concal_Q4FY25.pdf | f17ff721cb627242 |
| Concall | 2025-06-30 | TRANSCRIPT | — | Date_20250813_Emcure Pharmaceuticals Ltd._Concal_Q1FY26.pdf | e1fcfbdd3be3e12b |
| Concall | 2025-09-30 | TRANSCRIPT | — | Date_20251117_Emcure Pharmaceuticals Ltd._Concal_Q2FY26.pdf | 485b192dd81f3858 |
| Concall | 2025-12-31 | TRANSCRIPT | — | Date_20260210_Emcure Pharmaceuticals Ltd._Concal_Q3FY26.pdf | 9c1d3b914b529ec2 |
| Concall | 2026-03-31 | TRANSCRIPT | — | Date_20260511_Emcure Pharmaceuticals Ltd._Concal_Q4FY26.pdf | 5ad82936f8aaba79 |
| Concall | 2026-06-30 | TRANSCRIPT | — | Date_20260812_Emcure Pharmaceuticals Ltd._Concal_Q1FY27.pdf | ab809f86566416a9 |
| Shareholding XBRL | 2024-07-10 | — | — | SHP_188995_1467396_17062025111301_WEB.xm | 0579413e8dcdcff0 |
| Shareholding XBRL | 2024-09-30 | — | — | SHP_192999_1465410_11062025011030_WEB.xm | 2d091801d5cce5a4 |
| Shareholding XBRL | 2024-12-31 | — | — | SHP_195955_1465408_11062025010853_WEB.xm | 341cc885f8396b98 |
| Shareholding XBRL | 2025-03-31 | — | — | SHP_198669_1420876_21042025013203_WEB.xm | ea7d918353ecb1be |
| Shareholding XBRL | 2025-06-30 | — | — | SHP_1493751_25072025060814_WEB.xml | 6f649d32c524e00b |
| Shareholding XBRL | 2025-09-30 | — | — | SHP_1554419_20102025043450_WEB.xml | 49e24979094509cd |
| Shareholding XBRL | 2025-12-31 | — | — | SHP_1606131_20012026063915_WEB.xml | ec77627e2bddabbf |
| Shareholding XBRL | 2026-03-31 | — | — | SHP_1653522_17042026063721_WEB.xml | 2c89617efb5d4eaa |
| Shareholding XBRL | 2026-06-30 | — | — | SHP_1698017_21072026020152_WEB.xml | b082bbf4abdb0942 |
| Related-party XBRL | 2024-09-30 | — | — | RPT_1300598_07112024082832_WEB.xml | 76e5dc258b4571af |